Agios Pharmaceuticals Secures $8,800,000 New Funding

  • Feed Type
  • Date
    4/26/2010
  • Company Name
    Agios Pharmaceuticals
  • Mailing Address
    38 Sidney Street 2nd Floor Cambridge, MA 02139-4169
  • Company Description
    Agios is a biopharmaceutical company at the forefront of one of the most exciting new areas of cancer research: cancer metabolism. Cancer metabolism represents a breakthrough understanding of how cancer cells become addicted to using more nutrients than normal cells to ensure their survival and growth.
  • Website
    http://www.agios.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.